Global Cardiac Biomarkers Market 2023-2027

Description

List of Tables

Technavio has been monitoring the cardiac biomarkers market and is forecast to grow by $7880.86 mn during 2022-2027, accelerating at a CAGR of 12.6% during the forecast period. Our report on the cardiac biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of CVDs, growing geriatric population, and rising number of M&A and new product launches.

Technavio's cardiac biomarkers market is segmented as below:

By Technology

Conventional laboratory testing
POC testing

By Product

Troponin
BNP and NT-proBNP
CK-MB
Myoglobin
Others

By End-user

Hospitals
clinics
Diagnostic laboratories

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increased focus on personalized medicine as one of the prime reasons driving the cardiac biomarkers market growth during the next few years. Also, use of digital health in rapid diagnostics for POC and advances in technology will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cardiac biomarkers market covers the following areas:

Cardiac biomarkers market sizing
Cardiac biomarkers market forecast
Cardiac biomarkers market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac biomarkers market vendors that include Abbott Laboratories, Advanced ImmunoChemical Inc., BG Medicine Inc., Bio Rad Laboratories Inc., bioMerieux SA, Boditech Med Inc., Creative Diagnostics, Danaher Corp., Diazyme Laboratories Inc., F. Hoffmann La Roche Ltd., Lepu Medical Technology Beijing Co. Ltd., LifeSign LLC, LSI Medience Corp., Noavaran Payesh Aani Salamat. Co., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Response Biomedical Corp., Siemens Healthineers AG, Signosis Inc., AgPlus Diagnostics Ltd., and Tosoh Corp. Also, the cardiac biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74940

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 08: Executive Summary - Chart on Incremental Growth
Exhibit 09: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 11: Parent market
Exhibit 12: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 13: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 14: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global cardiac biomarkers market 2017 - 2021
Exhibit 19: Historic Market Size - Data Table on Global cardiac biomarkers market 2017 - 2021 ($ million)
4.2 Technology Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 End-user Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.5 Geography Segment Analysis 2017 - 2021
Exhibit 23: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.6 Country Segment Analysis 2017 - 2021
Exhibit 24: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 25: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 26: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 27: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 28: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 29: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 30: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 31: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Technology

6.1 Market segments
Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)
6.2 Comparison by Technology
Exhibit 34: Chart on Comparison by Technology
Exhibit 35: Data Table on Comparison by Technology
6.3 Conventional laboratory testing - Market size and forecast 2022-2027
Exhibit 36: Chart on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
Exhibit 37: Data Table on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
Exhibit 38: Chart on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
Exhibit 39: Data Table on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
6.4 POC testing - Market size and forecast 2022-2027
Exhibit 40: Chart on POC testing - Market size and forecast 2022-2027 ($ million)
Exhibit 41: Data Table on POC testing - Market size and forecast 2022-2027 ($ million)
Exhibit 42: Chart on POC testing - Year-over-year growth 2022-2027 (%)
Exhibit 43: Data Table on POC testing - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Technology
Exhibit 44: Market opportunity by Technology ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 45: Chart on Product - Market share 2022-2027 (%)
Exhibit 46: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 47: Chart on Comparison by Product
Exhibit 48: Data Table on Comparison by Product
7.3 Troponin - Market size and forecast 2022-2027
Exhibit 49: Chart on Troponin - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Data Table on Troponin - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Chart on Troponin - Year-over-year growth 2022-2027 (%)
Exhibit 52: Data Table on Troponin - Year-over-year growth 2022-2027 (%)
7.4 BNP and NT-proBNP - Market size and forecast 2022-2027
Exhibit 53: Chart on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Data Table on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
Exhibit 55: Chart on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
Exhibit 56: Data Table on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
7.5 CK-MB - Market size and forecast 2022-2027
Exhibit 57: Chart on CK-MB - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Data Table on CK-MB - Market size and forecast 2022-2027 ($ million)
Exhibit 59: Chart on CK-MB - Year-over-year growth 2022-2027 (%)
Exhibit 60: Data Table on CK-MB - Year-over-year growth 2022-2027 (%)
7.6 Myoglobin - Market size and forecast 2022-2027
Exhibit 61: Chart on Myoglobin - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on Myoglobin - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on Myoglobin - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on Myoglobin - Year-over-year growth 2022-2027 (%)
7.7 Others - Market size and forecast 2022-2027
Exhibit 65: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Product
Exhibit 69: Market opportunity by Product ($ million)

8 Market Segmentation by End-user

8.1 Market segments
Exhibit 70: Chart on End-user - Market share 2022-2027 (%)
Exhibit 71: Data Table on End-user - Market share 2022-2027 (%)
8.2 Comparison by End-user
Exhibit 72: Chart on Comparison by End-user
Exhibit 73: Data Table on Comparison by End-user
8.3 Hospitals and clinics - Market size and forecast 2022-2027
Exhibit 74: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 77: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
8.4 Diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 78: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 81: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
8.5 Market opportunity by End-user
Exhibit 82: Market opportunity by End-user ($ million)

9 Customer Landscape

9.1 Customer landscape overview
Exhibit 83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

10.1 Geographic segmentation
Exhibit 84: Chart on Market share by geography 2022-2027 (%)
Exhibit 85: Data Table on Market share by geography 2022-2027 (%)
10.2 Geographic comparison
Exhibit 86: Chart on Geographic comparison
Exhibit 87: Data Table on Geographic comparison
10.3 North America - Market size and forecast 2022-2027
Exhibit 88: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 91: Data Table on North America - Year-over-year growth 2022-2027 (%)
10.4 Europe - Market size and forecast 2022-2027
Exhibit 92: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 95: Data Table on Europe - Year-over-year growth 2022-2027 (%)
10.5 Asia - Market size and forecast 2022-2027
Exhibit 96: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 99: Data Table on Asia - Year-over-year growth 2022-2027 (%)
10.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 100: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 103: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
10.7 US - Market size and forecast 2022-2027
Exhibit 104: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 107: Data Table on US - Year-over-year growth 2022-2027 (%)
10.8 Germany - Market size and forecast 2022-2027
Exhibit 108: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 110: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 111: Data Table on Germany - Year-over-year growth 2022-2027 (%)
10.9 China - Market size and forecast 2022-2027
Exhibit 112: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 114: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 115: Data Table on China - Year-over-year growth 2022-2027 (%)
10.10 UK - Market size and forecast 2022-2027
Exhibit 116: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 117: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 118: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 119: Data Table on UK - Year-over-year growth 2022-2027 (%)
10.11 India - Market size and forecast 2022-2027
Exhibit 120: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 121: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 122: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 123: Data Table on India - Year-over-year growth 2022-2027 (%)
10.12 Market opportunity by geography
Exhibit 124: Market opportunity by geography ($ million)

11 Drivers, Challenges, and Trends

11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Exhibit 125: Impact of drivers and challenges in 2022 and 2027
11.4 Market trends

12 Vendor Landscape

12.1 Overview
12.2 Vendor landscape
Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
12.3 Landscape disruption
Exhibit 127: Overview on factors of disruption
12.4 Industry risks
Exhibit 128: Impact of key risks on business

13 Vendor Analysis

13.1 Vendors covered
Exhibit 129: Vendors covered
13.2 Market positioning of vendors
Exhibit 130: Matrix on vendor position and classification
13.3 Abbott Laboratories
Exhibit 131: Abbott Laboratories - Overview
Exhibit 132: Abbott Laboratories - Business segments
Exhibit 133: Abbott Laboratories - Key news
Exhibit 134: Abbott Laboratories - Key offerings
Exhibit 135: Abbott Laboratories - Segment focus
13.4 BG Medicine Inc.
Exhibit 136: BG Medicine Inc. - Overview
Exhibit 137: BG Medicine Inc. - Product / Service
Exhibit 138: BG Medicine Inc. - Key offerings
13.5 Bio Rad Laboratories Inc.
Exhibit 139: Bio Rad Laboratories Inc. - Overview
Exhibit 140: Bio Rad Laboratories Inc. - Business segments
Exhibit 141: Bio Rad Laboratories Inc. - Key news
Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
Exhibit 143: Bio Rad Laboratories Inc. - Segment focus
13.6 bioMerieux SA
Exhibit 144: bioMerieux SA - Overview
Exhibit 145: bioMerieux SA - Product / Service
Exhibit 146: bioMerieux SA - Key news
Exhibit 147: bioMerieux SA - Key offerings
13.7 Boditech Med Inc.
Exhibit 148: Boditech Med Inc. - Overview
Exhibit 149: Boditech Med Inc. - Key offerings
13.8 Creative Diagnostics
Exhibit 150: Creative Diagnostics - Overview
Exhibit 151: Creative Diagnostics - Product / Service
Exhibit 152: Creative Diagnostics - Key offerings
13.9 Diazyme Laboratories Inc.
Exhibit 153: Diazyme Laboratories Inc. - Overview
Exhibit 154: Diazyme Laboratories Inc. - Product / Service
Exhibit 155: Diazyme Laboratories Inc. - Key offerings
13.10 F. Hoffmann La Roche Ltd.
Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
13.11 Lepu Medical Technology Beijing Co. Ltd.
Exhibit 161: Lepu Medical Technology Beijing Co. Ltd. - Overview
Exhibit 162: Lepu Medical Technology Beijing Co. Ltd. - Product / Service
Exhibit 163: Lepu Medical Technology Beijing Co. Ltd. - Key offerings
13.12 LifeSign LLC
Exhibit 164: LifeSign LLC - Overview
Exhibit 165: LifeSign LLC - Product / Service
Exhibit 166: LifeSign LLC - Key offerings
13.13 LSI Medience Corp.
Exhibit 167: LSI Medience Corp. - Overview
Exhibit 168: LSI Medience Corp. - Product / Service
Exhibit 169: LSI Medience Corp. - Key offerings
13.14 Randox Laboratories Ltd.
Exhibit 170: Randox Laboratories Ltd. - Overview
Exhibit 171: Randox Laboratories Ltd. - Product / Service
Exhibit 172: Randox Laboratories Ltd. - Key offerings
13.15 Response Biomedical Corp.
Exhibit 173: Response Biomedical Corp. - Overview
Exhibit 174: Response Biomedical Corp. - Product / Service
Exhibit 175: Response Biomedical Corp. - Key offerings
13.16 Siemens Healthineers AG
Exhibit 176: Siemens Healthineers AG - Overview
Exhibit 177: Siemens Healthineers AG - Business segments
Exhibit 178: Siemens Healthineers AG - Key news
Exhibit 179: Siemens Healthineers AG - Key offerings
Exhibit 180: Siemens Healthineers AG - Segment focus
13.17 Signosis Inc.
Exhibit 181: Signosis Inc. - Overview
Exhibit 182: Signosis Inc. - Product / Service
Exhibit 183: Signosis Inc. - Key offerings

14 Appendix

14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Exhibit 184: Inclusions checklist
Exhibit 185: Exclusions checklist
14.3 Currency conversion rates for US$
Exhibit 186: Currency conversion rates for US$
14.4 Research methodology
Exhibit 187: Research methodology
Exhibit 188: Validation techniques employed for market sizing
Exhibit 189: Information sources
14.5 List of abbreviations
Exhibit 190: List of abbreviations
- investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.